Inspire Medical Systems (INSP) Stock Forecast & Price Target

Compare

807 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

INSP Analyst Ratings

Moderate Buy

6 Buy

12 Hold

0 Sell

Based on 18 analysts giving stock ratings to

Inspire

Medical Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

INSP Stock 12 Month Forecast

Average Price Target

$91.62

▲(53.91% Upside)

Based on 18 Wall Street analysts offering 12 month price targets for Inspire Medical Systems in the last 3 months. The average price target is $91.62 with a high forecast of $175.00 and a low forecast of $60.00. The average price target represents a 53.91% change from the last price of $59.53.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"$59","194":"$194","92.75":"$92.8","126.5":"$126.5","160.25":"$160.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$175.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":91.62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$91.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$60.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,92.75,126.5,160.25,194],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,81.26153846153846,89.07307692307693,96.88461538461539,104.69615384615385,112.50769230769231,120.31923076923077,128.13076923076923,135.94230769230768,143.75384615384615,151.56538461538463,159.37692307692308,167.18846153846152,{"y":175,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,74.84769230769231,76.24538461538462,77.64307692307693,79.04076923076923,80.43846153846154,81.83615384615385,83.23384615384616,84.63153846153847,86.02923076923078,87.42692307692309,88.82461538461538,90.2223076923077,{"y":91.62,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,72.41538461538462,71.38076923076923,70.34615384615385,69.31153846153846,68.27692307692308,67.24230769230769,66.20769230769231,65.17307692307692,64.13846153846154,63.10384615384615,62.06923076923077,61.034615384615385,{"y":60,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":193.5,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.98,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.81,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.51,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.38,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.08,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.34,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.23,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$175.00

Average Price Target$91.62

Lowest Price Target$60.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Patrick Wood

Morgan Stanley

$130→$60

Hold

0.79%

Upside

Reiterated

02/19/26

Inspire Medical price target lowered to $60 from $130 at Morgan StanleyInspire Medical price target lowered to $60 from $130 at Morgan Stanley

Michael Polark

Wolfe Research

Hold

―

Downgraded

02/13/26

Inspire Medical downgraded to Peer Perform from Outperform at Wolfe ResearchInspire Medical downgraded to Peer Perform from Outperform at Wolfe Research

Danielle Antalffy

UBS

$89→$67

Hold

12.55%

Upside

Reiterated

02/13/26

Inspire Medical price target lowered to $67 from $89 at UBSInspire Medical price target lowered to $67 from $89 at UBS

Adam Maeder

Piper Sandler

$165→$85

Buy

42.79%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Doximity (NYSE: DOCS), Atricure (NASDAQ: ATRC) and Inspire Medical Systems (NYSE: INSP)

Richard Newitter

Truist Financial

$96→$70

Hold

17.59%

Upside

Reiterated

02/12/26

Truist Financial Keeps Their Hold Rating on Inspire Medical Systems (INSP)

Christopher Pasquale

Nephron

Hold

―

Downgraded

02/12/26

Inspire Medical downgraded to Hold from Buy at Nephron ResearchInspire Medical downgraded to Hold from Buy at Nephron Research

Anthony Petrone

Mizuho Securities

$130→$85

Buy

42.79%

Upside

Reiterated

02/12/26

Inspire Medical price target lowered to $85 from $130 at MizuhoInspire Medical price target lowered to $85 from $130 at Mizuho

Robbie Marcus

J.P. Morgan

$118→$67

Hold

12.55%

Upside

Reiterated

02/12/26

Inspire Medical price target lowered to $67 from $118 at JPMorganInspire Medical price target lowered to $67 from $118 at JPMorgan

Jonathan Block

Stifel Nicolaus

$110→$95

Buy

59.58%

Upside

Reiterated

02/12/26

Inspire Medical price target lowered to $95 from $110 at StifelInspire Medical price target lowered to $95 from $110 at Stifel

David Rescott

Robert W. Baird

$130→$74

Hold

24.31%

Upside

Downgraded

02/12/26

Inspire Medical downgraded to Neutral from Outperform at BairdInspire Medical downgraded to Neutral from Outperform at Baird

Brett Fishbin

KeyBanc

Hold

―

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Inspire Medical Systems (NYSE: INSP) and Avantor (NYSE: AVTR)

Larry Biegelsen

Wells Fargo

$145→$70

Hold

17.59%

Upside

Downgraded

02/11/26

Inspire Medical downgraded to Equal Weight from Overweight at Wells FargoInspire Medical downgraded to Equal Weight from Overweight at Wells Fargo

Shagun Singh Chadha

RBC Capital

$90→$68

Hold

14.23%

Upside

Reiterated

02/11/26

RBC Capital Sticks to Its Hold Rating for Inspire Medical Systems (INSP)

Suraj Kalia

Oppenheimer

Hold

―

Downgraded

01/22/26

Inspire Medical downgraded to Perform from Outperform at OppenheimerInspire Medical downgraded to Perform from Outperform at Oppenheimer

Daniel Markowitz CFA

Evercore ISI

$125

Buy

109.98%

Upside

Reiterated

01/22/26

Analysts Are Bullish on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Inspire Medical Systems (INSP)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Patrick Wood

Morgan Stanley

$130→$60

Hold

0.79%

Upside

Reiterated

02/19/26

Inspire Medical price target lowered to $60 from $130 at Morgan StanleyInspire Medical price target lowered to $60 from $130 at Morgan Stanley

Michael Polark

Wolfe Research

Hold

―

Downgraded

02/13/26

Inspire Medical downgraded to Peer Perform from Outperform at Wolfe ResearchInspire Medical downgraded to Peer Perform from Outperform at Wolfe Research

Danielle Antalffy

UBS

$89→$67

Hold

12.55%

Upside

Reiterated

02/13/26

Inspire Medical price target lowered to $67 from $89 at UBSInspire Medical price target lowered to $67 from $89 at UBS

Adam Maeder

Piper Sandler

$165→$85

Buy

42.79%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Doximity (NYSE: DOCS), Atricure (NASDAQ: ATRC) and Inspire Medical Systems (NYSE: INSP)

Richard Newitter

Truist Financial

$96→$70

Hold

17.59%

Upside

Reiterated

02/12/26

Truist Financial Keeps Their Hold Rating on Inspire Medical Systems (INSP)

Christopher Pasquale

Nephron

Hold

―

Downgraded

02/12/26

Inspire Medical downgraded to Hold from Buy at Nephron ResearchInspire Medical downgraded to Hold from Buy at Nephron Research

Anthony Petrone

Mizuho Securities

$130→$85

Buy

42.79%

Upside

Reiterated

02/12/26

Inspire Medical price target lowered to $85 from $130 at MizuhoInspire Medical price target lowered to $85 from $130 at Mizuho

Robbie Marcus

J.P. Morgan

$118→$67

Hold

12.55%

Upside

Reiterated

02/12/26

Inspire Medical price target lowered to $67 from $118 at JPMorganInspire Medical price target lowered to $67 from $118 at JPMorgan

Jonathan Block

Stifel Nicolaus

$110→$95

Buy

59.58%

Upside

Reiterated

02/12/26

Inspire Medical price target lowered to $95 from $110 at StifelInspire Medical price target lowered to $95 from $110 at Stifel

David Rescott

Robert W. Baird

$130→$74

Hold

24.31%

Upside

Downgraded

02/12/26

Inspire Medical downgraded to Neutral from Outperform at BairdInspire Medical downgraded to Neutral from Outperform at Baird

Brett Fishbin

KeyBanc

Hold

―

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Inspire Medical Systems (NYSE: INSP) and Avantor (NYSE: AVTR)

Larry Biegelsen

Wells Fargo

$145→$70

Hold

17.59%

Upside

Downgraded

02/11/26

Inspire Medical downgraded to Equal Weight from Overweight at Wells FargoInspire Medical downgraded to Equal Weight from Overweight at Wells Fargo

Shagun Singh Chadha

RBC Capital

$90→$68

Hold

14.23%

Upside

Reiterated

02/11/26

RBC Capital Sticks to Its Hold Rating for Inspire Medical Systems (INSP)

Suraj Kalia

Oppenheimer

Hold

―

Downgraded

01/22/26

Inspire Medical downgraded to Perform from Outperform at OppenheimerInspire Medical downgraded to Perform from Outperform at Oppenheimer

Daniel Markowitz CFA

Evercore ISI

$125

Buy

109.98%

Upside

Reiterated

01/22/26

Analysts Are Bullish on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Inspire Medical Systems (INSP)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Inspire Medical Systems

3 Months

xxx

Success Rate

11/18 ratings generated profit

Average Return

+8.14%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 61.11% of your transactions generating a profit, with an average return of +8.14% per trade.

1 Year

Jonathan BlockStifel Nicolaus

Success Rate

11/18 ratings generated profit

Average Return

+36.54%

reiterated a buy rating 11 days ago

Copying Jonathan Block's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +36.54% per trade.

2 Years

xxx

Success Rate

11/18 ratings generated profit

Average Return

+70.91%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 61.11% of your transactions generating a profit, with an average return of +70.91% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

INSP Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, INSP has received 43 Buy Ratings, 42 Hold Ratings, and 0 Sell Ratings. INSP average Analyst price target in the past 3 months is 91.62.

Each month's total comprises the sum of three months' worth of ratings.

INSP Financial Forecast

INSP Earnings Forecast

Next quarter’s earnings estimate for INSP is -$0.30 with a range of -$1.02 to -$0.01. The previous quarter’s EPS was $1.65. INSP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year INSP has Performed in-line its overall industry.

INSP Sales Forecast

Next quarter’s sales forecast for INSP is $201.39M with a range of $200.10M to $203.72M. The previous quarter’s sales results were $269.08M. INSP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year INSP has Performed in-line its overall industry.

INSP Stock Forecast FAQ

What is INSP’s average 12-month price target, according to analysts?

Based on analyst ratings, Inspire Medical Systems’s 12-month average price target is 91.62.

What is INSP’s upside potential, based on the analysts’ average price target?

Inspire Medical Systems has 53.91% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is INSP a Buy, Sell or Hold?

Inspire Medical Systems has a consensus rating of Moderate Buy which is based on 6 buy ratings, 12 hold ratings and 0 sell ratings.

What is Inspire Medical Systems’s price target?

The average price target for Inspire Medical Systems is 91.62. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $175.00 ,the lowest forecast is $60.00. The average price target represents 53.91% Increase from the current price of $59.53.

What do analysts say about Inspire Medical Systems?

Inspire Medical Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.

How can I buy shares of INSP?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Inspire Medical Systems (INSP) Stock Forecast & Price Target

INSP Analyst Ratings

INSP Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Inspire Medical Systems

INSP Analyst Recommendation Trends

INSP Financial Forecast

INSP Earnings Forecast

INSP Sales Forecast

INSP Stock Forecast FAQ

Detailed List of Analyst Forecasts